Drug slows Alzheimer's by 60% for mildly impaired patients in trial

Drug slows Alzheimer's by 60% for mildly impaired patients in trial
play icon
Dr Seth Gale points out evidence of Alzheimer?s disease on PET scans at the Center for Alzheimer Research and Treatment at Brigham And Women's Hospital in Boston. File / Reuters